LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-0.19 Cr | ₹-10 Cr | ₹6.26 Cr | ₹1.27 Cr | ₹2.15 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LASA SUPERGENERICS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-0.19 Cr |
Mar2023 | ₹-10 Cr |
Mar2022 | ₹6.26 Cr |
Mar2021 | ₹1.27 Cr |
Mar2020 | ₹2.15 Cr |
How is Net Cash Inflow / Outflow of LASA SUPERGENERICS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-0.19 Cr | Negative | |
Mar2023 | ₹-10 Cr | Negative | |
Mar2022 | ₹6.26 Cr | 392.83 | |
Mar2021 | ₹1.27 Cr | -40.88 | |
Mar2020 | ₹2.15 Cr | - |
Compare Net Cash Inflow / Outflow of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹70.3 Cr | -6.5% | -15.8% | -38.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -6.5% |
-15.8% |
-38.2% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses